RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Thickness of retina and choroid in the elderly population and its association with Complement Factor H polymorphism: KLoSHA Eye study

PLoS One 13(12):e0209276 · 2018 · PMID 30596689

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

88편 검색→87편 판독→35편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Retinal and choroidal thickness and complement factor H polymorphisms in older adults (retinal thickness[tiab] OR choroidal thickness[tiab] OR retinal thickness measurement[tiab] OR choroidal thickness measurement[tiab] OR macular thickness[tiab] OR optical coherence tomography[tiab] OR OCT[tiab]) AND (complement factor H[tiab] OR CFH[tiab] OR CFH polymorphism[tiab] OR complement factor H polymorphism[tiab] OR rs1061170[tiab] OR complement factor H gene[tiab]) AND (aged[mh] OR older adults[tiab] OR elderly[tiab] OR aging[tiab])

출판 연도

2012: 1편120122013: 4편42014: 3편32015: 3편320152016: 4편42017: 2편22018: 2편22019: 1편12020: 4편420202021: 2편22022: 4편42024: 1편12025: 3편32026: 1편12026

선별된 35편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01spectral-domain optical · color fundus13편

  1. 0.96

    Thickness of retina and choroid in the elderly population and its association with Complement Factor H polymorphism: KLoSHA Eye study 이 논문

    Ryoo NK, Ahn SJ, Park KH et al. · PloS one · 2018

  2. 0.87

    Incidence and Risk Factors of Reticular Pseudodrusen Using Multimodal Imaging

    Dutheil C, Le Goff M, Cougnard-Gregoire A et al. · JAMA ophthalmology · 2020

  3. 0.86

    Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy

    Jirarattanasopa P, Ooto S, Nakata I et al. · Investigative ophthalmology & visual science · 2012

  4. 0.84

    GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY

    Yoneyama S, Sakurada Y, Kikushima W et al. · Retina (Philadelphia, Pa.) · 2016

  5. 0.82

    Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration

    Yoneyama S, Sakurada Y, Mabuchi F et al. · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2014

  6. 0.81

    Characteristics of intermediate age-related macular degeneration with hyperreflective foci

    Kikushima W, Sakurada Y, Sugiyama A et al. · Scientific reports · 2022

  7. 0.78

    Distinct characteristics of central serous chorioretinopathy according to gender

    Yoneyama S, Fukui A, Sakurada Y et al. · Scientific reports · 2022

  8. 0.74

    Clinical and Genetic Characteristics of Pachydrusen in Eyes with Central Serous Chorioretinopathy and General Japanese Individuals

    Takahashi A, Hosoda Y, Miyake M et al. · Ophthalmology. Retina · 2021

  9. 0.66

    CHOROIDAL VASCULARITY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND ITS ASSOCIATION WITH RISK SINGLE-NUCLEOTIDE POLYMORPHISMS

    Kaye RA, Peto T, Hogg R et al. · Retina (Philadelphia, Pa.) · 2024

  10. 0.59

    HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvement

    Farashi S, Abbott CJ, Ansell BRE et al. · Nature communications · 2025

  11. 0.58

    Choroidal neovascularization in eyes with choroidal vascular hyperpermeability

    Miyake M, Tsujikawa A, Yamashiro K et al. · Investigative ophthalmology & visual science · 2014

  12. 0.57

    Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration

    Shijo T, Sakurada Y, Yoneyama S et al. · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2017

  13. 0.53

    Clinical and genetic characteristics of simple central serous chorioretinopathy according to age

    Shijo T, Fukui A, Sakurada Y et al. · Ophthalmic genetics · 2025

02visual acuity · treatment13편

  1. 0.81

    Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography

    Teper SJ, Nowinska A, Pilat J et al. · Photodiagnosis and photodynamic therapy · 2016

  2. 0.78

    The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers

    Luo M, Zhao X, Yang J et al. · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020

  3. 0.70

    Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration

    Shah AR, Williams S, Baumal CR et al. · American journal of ophthalmology · 2016

  4. 0.69

    Association between Polymorphisms in CFH, ARMS2, CFI, and C3 Genes and Response to Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration

    Kozhevnikova OS, Fursova AZ, Derbeneva AS et al. · Biomedicines · 2022

  5. 0.66

    Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population

    Medina FMC, Motta AALd, Takahashi WY et al. · Ophthalmic research · 2019

  6. 0.64

    Pharmacogenetic Effect of Complement Factor H Gene Polymorphism in Response to the Initial Intravitreal Injection of Bevacizumab for Wet Age-Related Macular Degeneration

    Medina FMC, Alves Lopes da Motta A, Takahashi WY et al. · Ophthalmic research · 2015

  7. 0.60

    Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration

    Matsumiya W, Honda S, Yanagisawa S et al. · Pharmacogenomics · 2014

  8. 0.60

    Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy

    Kawashima Y, Oishi A, Tsujikawa A et al. · Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2015

  9. 0.56

    Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

    Cobos E, Recalde S, Anter J et al. · Acta ophthalmologica · 2018

  10. 0.56

    Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy

    Wataru K, Sugiyama A, Yoneyama S et al. · PloS one · 2020

  11. 0.53

    Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population

    Yuan D, Yuan D, Liu X et al. · Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2013

  12. 0.51

    Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population

    Chang W, Noh DH, Sagong M et al. · Molecular vision · 2013

  13. 0.51

    The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab

    Dikmetas O, Kadayifcilar S, Eldem B · Molecular vision · 2013

03disease · drusen9편

  1. 0.85

    Genetic Polymorphisms and the Phenotypic Characterization of Individuals with Early Age-Related Macular Degeneration

    Oeverhaus M, Meyer Zu Westrup V, Dietzel M et al. · Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde · 2017

  2. 0.83

    Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Maguire MG, Ying GS, Jaffe GJ et al. · JAMA ophthalmology · 2016

  3. 0.80

    Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10

    Zouache MA, Bennion A, Hageman JL et al. · Scientific reports · 2020

  4. 0.78

    Pachychoroid neovasculopathy and age-related macular degeneration

    Miyake M, Ooto S, Yamashiro K et al. · Scientific reports · 2015

  5. 0.77

    Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration: Epidemiologic and Genetic Evidence from UK Biobank OCT Data

    Zekavat SM, Sekimitsu S, Ye Y et al. · Ophthalmology · 2022

  6. 0.71

    Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration

    Cao S, Ko A, Partanen M et al. · American journal of ophthalmology · 2013

  7. 0.69

    Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients

    Krytkowska E, Ulanczyk Z, Grabowicz A et al. · Investigative ophthalmology & visual science · 2021

  8. 0.58

    Rare predicted loss-of-function and damaging missense variants in CFHR5 associate with protection from age-related macular degeneration

    Holleman AM, Deaton AM, Hoffing RA et al. · American journal of human genetics · 2025

  9. 0.53

    Impact of age-related maculopathy susceptibility 2, high-temperature requirement A serine peptidase 1, and complement factor H genetic variants on clinical phenotypes of age-related macular degeneration

    Ranga D, Kaur S, Nallabelli N et al. · Indian journal of ophthalmology · 2026